Literature DB >> 23317075

Evaluation and management of corneal abrasions.

Jennifer L Wipperman1, John N Dorsch.   

Abstract

Corneal abrasions are commonly encountered in primary care. Patients typically present with a history of trauma and symptoms of foreign body sensation, tearing, and sensitivity to light. History and physical examination should exclude serious causes of eye pain, including penetrating injury, infective keratitis, and corneal ulcers. After fluorescein staining of the cornea, an abrasion will appear yellow under normal light and green in cobalt blue light. Physicians should carefully examine for foreign bodies and remove them, if present. The goals of treatment include pain control, prevention of infection, and healing. Pain relief may be achieved with topical nonsteroidal anti-inflammatory drugs or oral analgesics. Evidence does not support the use of topical cycloplegics for uncomplicated corneal abrasions. Patching is not recommended because it does not improve pain and has the potential to delay healing. Although evidence is lacking, topical antibiotics are commonly prescribed to prevent bacterial superinfection. Contact lens-related abrasions should be treated with antipseudomonal topical antibiotics. Follow-up may not be necessary for patients with small (4 mm or less), uncomplicated abrasions; normal vision; and resolving symptoms. All other patients should be reevaluated in 24 hours. Referral is indicated for any patient with symptoms that do not improve or that worsen, a corneal infiltrate or ulcer, significant vision loss, or a penetrating eye injury.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23317075

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  21 in total

Review 1.  Corneal injury: Clinical and molecular aspects.

Authors:  Brayden Barrientez; Sarah E Nicholas; Amy Whelchel; Rabab Sharif; Jesper Hjortdal; Dimitrios Karamichos
Journal:  Exp Eye Res       Date:  2019-06-22       Impact factor: 3.467

2.  Ocular surface injury after shoulder surgery in the beach-chair position.

Authors:  Jung Youn Kim; Yong Girl Rhee
Journal:  Int Orthop       Date:  2018-06-26       Impact factor: 3.075

Review 3.  [Fireworks injuries of the eye: an overview of current diagnostic and treatment options].

Authors:  A Wolf; W Schrader; H Agostini; A Gabel-Pfisterer
Journal:  Ophthalmologe       Date:  2019-12       Impact factor: 1.059

4.  Gelam honey promotes ex vivo corneal fibroblasts wound healing.

Authors:  Alia Md Yusof; Norzana Abd Ghafar; Taty Anna Kamarudin; Kien-Hui Chua; Muhammad Fairuz Azmi; Sook-Luan Ng; Yasmin Anum Mohd Yusof
Journal:  Cytotechnology       Date:  2019-10-12       Impact factor: 2.058

Review 5.  Antibiotic prophylaxis for corneal abrasion.

Authors:  Abdullah M Algarni; Gordon H Guyatt; Angus Turner; Saad Alamri
Journal:  Cochrane Database Syst Rev       Date:  2022-05-27

Review 6.  Diabetic keratopathy: Insights and challenges.

Authors:  S Priyadarsini; A Whelchel; S Nicholas; R Sharif; K Riaz; D Karamichos
Journal:  Surv Ophthalmol       Date:  2020-02-22       Impact factor: 6.048

7.  Effect of topical administration of tramadol on corneal wound healing in rats.

Authors:  Ozgun Cuvas Apan; Murat Atabey Ozer; Selcuk Takir; Alparslan Apan; Demet Sengul
Journal:  Int Ophthalmol       Date:  2016-01-28       Impact factor: 2.031

Review 8.  Ocular Related Sports Injuries.

Authors:  Oded Ohana; Chris Alabiad
Journal:  J Craniofac Surg       Date:  2021-06-01       Impact factor: 1.172

9.  The cellular basis for biocide-induced fluorescein hyperfluorescence in mammalian cell culture.

Authors:  May M Bakkar; Luke Hardaker; Peter March; Philip B Morgan; Carole Maldonado-Codina; Curtis B Dobson
Journal:  PLoS One       Date:  2014-01-28       Impact factor: 3.240

Review 10.  Induced Pluripotent Stem Cells: Development in the Ophthalmologic Field.

Authors:  Nan Wu; Marianne Doorenbos; Dong Feng Chen
Journal:  Stem Cells Int       Date:  2016-08-10       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.